Smoking
Pipeline by Development Stage
Drug Modality Breakdown
On Market (1)
Approved therapies currently available
Competitive Landscape
22 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Showing 15 of 42 trials with date data
Clinical Trials (42)
Total enrollment: 13,374 patients across 42 trials
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
Melatonin in Smoke-induced Vascular Injury
Varenicline for Light Smokers
Improving the Population-Wide Effectiveness of U.S. Tobacco Cessation Quitlines
Long-term Varenicline Treatment for Smoking Cessation
PET Imaging Study on Occupancy of Dopamine D2 Receptors and Genotypes After Bupropion Administration
Bupropion for Hospitalized Smokers With Acute Cardiovascular Disease
Tobacco Tactics Website for Operating Engineers
A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse
Assessment of V0018 1.5 mg Effect on Craving
Effectiveness of Nicotine Replacement Therapy in Reducing the Risk of Nicotine Exposure in Pregnant Minority Smokers
A Study to Investigate a Research Drug as an Aid for Smoking Cessation in Chronic Cigarette Smokers (0364-007)
A Study of the Efficacy and Safety of Varenicline in Japanese Smokers Motivated to Quit Smoking
Smoking Cessation Assistance With LIBERTAL, A Phospholipid Mixture
Exercise, Smoking Cessation and Adolescents
A Study to Assess the Safety and Tolerability of Different Doses of PF-05402536 and PF-06413367 in Healthy Adult Smokers.
A Pharmacokinetic Evaluation of Two Nicotine Patches in Smokers
Bupropion and Cigarette-Related Cues in Smokers
Effect of Helpers Program On-line Training on Smoking Relapse and Social Networks
Effects of a Specific Substance in Smokers
Electronic Hookah and Endothelial Cell Function
Korean Youth Smoking Cessation Study
Sensory Perception of Sweet Flavors in E-Cigarette
Novel Approaches to Reducing Tobacco Related Harm
Insular Inhibitory Neuromodulation to Reduce Cigarette Craving and Alter Brain Function in Smokers
Integrative-omics of the Disordered COPD Small Airway Epithelium
Web and Mobile Smoking Cessation
Tailored Inhibitory Control Training to Reverse EA-linked Deficits in Mid-life
Web and Phone Intervention to Maintain Postpartum Tobacco Abstinence
Brief Intervention Study for Quitting Smoking
Cessation Service Use and Effectiveness for Hospitalized Smokers
Effect of Resistance Training on Tobacco-Related Cardiovascular Disease Risk
Physiological Responses in Tobacco Chippers
Using Group Commitment for Smoking Cessation
Prevention of Postpartum Smoking Relapse in Mothers of Infants in the Neonatal Intensive Care Unit (NICU)
Varenicline in Bipolar Depressed Patients
Youth Smoking Cessation: Therapy +/- "The Patch"
Smoking Cessation Program in the Preadmission Clinic: The Use of a Teachable Moment
Stop Smoking Therapy for Ontario Patients
Monoamine Oxidases in Smoking Pregnant Women and Newborns
Checking Smoking Status as a Routine Vital Sign: A Cluster-Randomized Trial of Its Effect on Cessation Counseling
Anti-Smoking Program for Parents: Effects on Child Smoking
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.